VIVUS to Present at Four Upcoming Investor Conferences
MOUNTAIN VIEW, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc.
(Nasdaq:VVUS) today announced that management will present an overview of the
company at four investment conferences during the months of April and May
The conference presentation schedule is as follows:
Needham 12th Annual Healthcare Conference
April 30, 2013, 1:40pm EDT
Westin Grand Central Hotel
New York, NY
Bank of America Merrill Lynch 2013 Health Care Conference
May 15, 2013, 4:20pm PDT
Encore at the Wynn
Las Vegas, NV
BioEquity Europe 2013
May 23, 2013, 10:30am CEST
Deutsche Bank 38th Annual dbAccess Health Care Conference
May 30, 2013, 3:30pm EDT
Westin Boston Waterfront Hotel
A live webcast and 30-day archive of the presentations will be available at
VIVUS is a biopharmaceutical company commercializing and developing
innovative, next-generation therapies to address unmet needs in obesity, sleep
apnea, diabetes and sexual health. For more information about the company,
please visit www.vivus.com.
Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely,"
"may," "plan," "potential," "predict," "opportunity" and "should," among
others. There are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in VIVUS' Form
10-K for the year ending December 31, 2012, and periodic reports filed with
the Securities and Exchange Commission.
CONTACT: VIVUS, Inc.
Timothy E. Morris
Chief Financial Officer
Financial Media Relations:
Joele Frank, Wilkinson Brimmer Katcher
The Trout Group
Press spacebar to pause and continue. Press esc to stop.